~~<i id='D0DC79C6A7'><strike id='D0DC79C6A7'><tt id='D0DC79C6A7'><pre id='D0DC79C6A7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：fashion 2025-09-30 14:08:13 - browse：3345

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： What to expect as Trump is arraigned on his Jan 6. indictment

entertainment

leisure time

focus

Wikipedia

explore

Wikipedia

ALAINJOCARD/AFPviaGettyImagesFormorethan30years,Alzheimer’sresearchershavethoughtofAPOE4asamajorgene

WSS

Bird flu reported in person exposed to presumably infected cattle

Young boy dies in trial for Pfizer Duchenne gene therapy

New safety details link Apellis eye drug to rare cases of blindness

5 important ways Henrietta Lacks changed medical science

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Hundreds died while taking an arthritis drug, but nobody alerted patients

focus

hotspot

entertainment

Drug repurposing or repositioning? The language matters

Pence says 'crackpot lawyers' told Trump what he wanted to hear

In Memoriam: Notable people who died in 2023

Researchers test human milk's ability to repair gut microbiome

Cancer drug shortages should be causing more outrage

Republican states more likely to report Covid vaccine side effects

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pence says 'crackpot lawyers' told Trump what he wanted to hear

United colonoscopy coverage change 'may cost lives,' doctors say

Amazon expands telehealth clinic nationwide

leisure time

Pancreatic cancer is often deadly, but new discoveries are raising hope

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Florida Supreme Court upholds state's abortion ban

NIH launches clinical trials and new research office for long Covid

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

focus

Wikipedia

explore

Wikipedia